• AbbVie, Eisai Launch Humira Pen Auto-injector in Japan for JA, Other Conditions
  • Adults With JA Have Increased Risk of Developing Metabolic Syndrome, Survey Says
  • Fun Summer Activities for Kids with Juvenile Arthritis
  • Adalimumab Shows Better Long-term Results than Infliximab for JIA-associated Uveitis, Study Finds
  • ANCON Raises Awareness for Juvenile Idiopathic Arthritis Via #WearPurpleforJIA Day
  • Don’t Let Juvenile Arthritis Make You Fearful of the Future
  • Depression in JIA Patients May Predict Long-term Pain and Disability, Study Finds
  • Lupin Seeking Marketing Approval in Europe for YLB113, Etanercept Biosimilar
  • Dealing with Morning Stiffness from Juvenile Arthritis
  • Actemra Treatment Linked to Disease Remission in Systemic JIA, German Registry Shows
  • FDA Approves Subcutaneous Form of Actemra for Active Polyarticular JIA
  • How to Deal with Clumsiness from Juvenile Arthritis